Senior insider sale
Chief Scientific Officer at ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$1.89M
110K shares
What this filing means
ROBINS HARLAN S plans to sell 110K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $1.89M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/15/2026ACC: 0001958244-26-000379
Officer· Chief Scientific Officer
Since Jun 2019
110K
Shares to sell
$1.89M
Approx. market value
100K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months3
Acquired as compensation -- Performance Awards
Compensation
3/7/2026
41.25KAcquired as compensation -- Performance Awards
Compensation
3/7/2026
47.50KAcquired as compensation -- Performance Awards
Compensation
3/7/2026
11.25KTotal acquired100K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/7/2026 | Acquired as compensation -- Performance Awards Compensation | 41.25K | — |
3/7/2026 | Acquired as compensation -- Performance Awards Compensation | 47.50K | — |
3/7/2026 | Acquired as compensation -- Performance Awards Compensation | 11.25K | — |
| Total | 100K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
10K
Market value
$148.3K
4/8/2026
Planned — Approximate Date
NASDPlanned
Units to sell
100K
Market value
$1.75M
6/15/2026
Total
Units
110K
Value
$1.89M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/8/2026 | 10K | $148.3K | — | Completed |
| Planned — Approximate Date | ||||
6/15/2026 | 100K | $1.75M | NASD | Planned |
| Total | 110K | $1.89M | ||